McKesson Corporation (NYSE:MCK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 10, Deutsche ...

McKesson saw strong 2025 growth from GLP-1 tailwinds, but fading momentum, weak margins, and a 21x forward P/E show ...

If you are wondering whether McKesson still looks attractive after its strong run, or whether much of the potential upside is ...

McKesson trades at $825.38 and has moved in lockstep with the market. Its shares have returned 14.5% over the last six months ...

A medical supplies distributor closed its Rock Hill warehouse and laid off nearly 180 workers earlier this year, and now an Atlanta-based investor has purchased the facility. Its time to invest in ...

The deal will secure part of Cencora's customer base for lucrative cancer drugs. The Conshohocken company also control a ...

Chicago-based Zuckerman Investment Group increased its Henry Schein position by 72,040 shares in the third quarter. The overall position value went up by about $3.38 million from the previous period.

Cencora, Inc. (NYSE: COR) is one of the stocks Jim Cramer recently discussed. During the lightning round, a caller inquired ...

Thirteen large distributors appeared on the second annual list that is based on analysis of more than 100 metrics across 11 ...

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been producing dubious science.

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $300 billion in annual US healthcare distribution sales, Cencora supplies ...

The global market for Antibacterial Products was valued at US$26.1 Billion in 2024 and is projected to reach US$29.8 Billion by 2030, growing at a CAGR of 2.2% from 2024 to 2030.